KSKatia Mohand Saidi

Katia Mohand Saidi

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Katia Mohand Saidi has a total of 39 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Synthesis, Computational Evaluation, and Anticancer Assessment of Benzofuran-Based Pyrano[2,3- c ]pyrazole Derivatives

    by Bassam A. Najri, Elena Daniela Hutanu, Amine Hafis Abdelsalam, Katia Mohand Saidi, Sevki Arslan, Arif Kivrak

    A new series of benzofuran-based pyrano[2,3-c]pyrazole derivatives 4a–e was synthesized and evaluated through integrated synthetic, computational, and biological studies. The target compounds were prepared via a multistep route involving Sonogashira coupling, iodine-mediated cyclization, Suzuki–Miyaura coupling, and final K2CO3-mediated one-pot cyclocondensation under mild reaction conditions. The optimized protocol afforded the desired derivatives in high to excellent yields (88–98%), and their structures were confirmed by 1H NMR, 13C NMR, and HRMS analyses. ADMET prediction indicated acceptable drug-likeness profiles, favorable intestinal permeability, and low predicted toxicity risks for the synthesized derivatives. Molecular docking studies against CDK2, the androgen receptor, VEGFR2, and Bcl-2 yielded favorable docking scores and predicted ligand-residue interactions within the selected binding pockets. Among the synthesized compounds, 4c showed the most favorable docking scores toward CDK2 and the androgen receptor, whereas 4a showed the most favorable scores toward VEGFR2 and Bcl-2. The most favorable complexes obtained from molecular docking were further examined by 100 ns molecular dynamics simulations, where RMSD, RMSF, and Rg analyses supported their dynamic stability and structural compactness during the simulation period. Biological evaluation demonstrated moderate, cell line-dependent antiproliferative activity, with 4a showing the lowest EC50 values against A549 and LNCaP cells (75.58 and 86.40 μM, respectively). Mechanistic assays indicated that the active derivatives promoted apoptosis, regulated apoptosis-related gene expression, suppressed cell migration and colony formation, enhanced intracellular ROS generation, disrupted mitochondrial membrane potential, and affected cell-cycle progression. These findings suggest that benzofuran-based pyrano[2,3-c]pyrazoles represent biologically relevant heterocyclic scaffolds with measurable anticancer activity supported by computational and cellular evidence.

  • Design, synthesis, and multi-layered computational validation of Novel 3,4-dihydropyrimidinone–benzamide hybrids as potential ER-α antagonists against MCF-7 breast cancer

    by Roufida Aichouna, Katia Mohand Saidi, Idriss Layoul, Mohamed Zakaria Stiti, Tahir Habila, Kamel Harrouche, Elif Apohan, Ayfer Kiliç, Hasan Küçükbay, Smail Khelili

  • Earth‐Abundant Mica Minerals as Cost‐Effective Catalysts for Hydrogen Peroxide Electrooxidation in Alkaline Media: Experimental and DFT Insights

    by Katia Mohand Saidi, Bassam A. Najri, Beray Alyakut, Özgür Karaoğlu, Sefika Kaya, Elif Varol Muratçay, Işıl Tokcan, Arif Kivrak, Hilal Kivrak

    The development of sustainable and cost‐effective catalysts for hydrogen peroxide (H 2 O 2 ) electrooxidation is crucial for advancing green energy technologies. In this study, we systematically investigate three natural mica minerals, biotite (Bt), margarite (Mg), and muscovite (Ms), as potential electrocatalysts for H 2 O 2 oxidation in alkaline media. The minerals were characterized by X‐ray diffraction (XRD), Fourier transform infrared (FTIR) spectroscopy, scanning electron microscopy (SEM), energy‐dispersive X‐ray spectroscopy (EDS), and Brunauer–Emmett–Teller (BET) surface area analysis. Three electrochemical methods were used: cyclic voltammetry (CV), electrochemical impedance spectroscopy (EIS), and chronoamperometry (CA). Ms was identified as the most active mineral, with the highest net H 2 O 2 oxidation current density of 15.29 mA/cm 2 . The Tafel plot yielded a Tafel slope of 137.05 mV/dec, while a turnover frequency (TOF) of 1.24 × 10 −1 s −1 was obtained, indicating fast electron‐transfer kinetics and high intrinsic catalytic activity. Chronoamperometric analysis confirmed the short‐term operational stability of Ms, while DFT calculations provided supportive insight into its electronic structure and charge‐transfer capability. The HOMO‐LUMO energy gap was moderate, at 2.367 eV, suggesting that the compound would exhibit good energetic stability and electron‐transfer efficiency during the reaction process. These results demonstrate that Ms is a promising low‐cost and environmentally benign catalyst for H 2 O 2 electrooxidation.

  • Design and Synthesis of Benzofuran‐1,4‐dihydropyridine Hybrids as Novel Anti‐Inflammatory Agents: Theoretical Exploration of a Potential Dual COX‐2/TNF‐α Mechanism

    by Katia Mohand Saidi, Bassam A. Najri, Smail Khelili, Kamel Harrouche, Mohamed Zakaria Stiti, Elyes Kelai, Abdelmadjid Guendouzi, Tahir Habila, Arif Kivrak

    This research presents the design, synthesis, and thorough evaluation of a new series of benzofuran‐1,4‐dihydropyridine hybrids ( 4a–i ) as potential multi‐target anti‐inflammatory drugs. These compounds were created through an optimized multistep process and examined using a combination of in silico, in vitro, and in vivo methods. Molecular docking revealed a potential dual‐target profile, with the leading compounds showing strong predicted binding to both COX‐2 and TNF‐α. Notably, compound 4i demonstrated the highest affinity for COX‐2 (MolDock score = −181.002 kcal/mol), with good selectivity over COX‐1 (Δ = −21.35), and also showed one of the strongest affinities for TNF‐α (−174.847 kcal/mol). Molecular dynamics simulations confirmed the stability of the 4i ‐COX‐2 complex. This in silico effectiveness was supported by strong in vitro anti‐inflammatory activity (eg. 10.09 µg/mL for IC 50 of 4b in hypotonicity‐induced hemolysis). Notably, the compounds showed excellent in vivo activity in a carrageenan‐induced paw edema model, with 4i achieving 91.5% inhibition at 90 min. Histological analysis confirmed that the lead compounds were highly gastrointestinal (GI)‐sparing, consistent with their predicted COX‐2 selectivity. No liver damage was observed, and platelet count remained normal ( 4i ). Overall, this study identifies compound 4i as a potent, orally active, and safe antinflammatory candidate with potential dual mechanisms.


  • Design, Synthesis, and Integrated Computational Evaluation of Novel Quinoline Hydrazones as Dual‐Action Anti‐Inflammatory and Antibacterial Agents

    by Bachir Douara, Katia Mohand Saidi, Lotfi Belkhiri, Nassima Boutaoui, Mohamed Zakaria Stiti, Smail Khelili, Ramzi Maadadi, Abdelmadjid Guendouzi, Abdelkrim Guendouzi

    Addressing both bacterial infections and inflammation necessitates the development of innovative therapeutic strategies that mitigate the risks associated with polypharmacy. The targeted quinoline hydrazone derivatives ( 6a – j ) were synthesized via a two‐step process, beginning with the preparation of the essential quinoline hydrazide intermediate 5 , followed by its condensation with substituted aromatic aldehydes. Advanced spectroscopic techniques, including 1 H NMR, 13 C NMR, and HRMS, confirmed their structures. Comprehensive computational studies, comprising DFT, molecular docking, and molecular dynamics, were performed to establish structure–activity relationships and substantiate the biological results. The derivatives exhibited notable dual activity; specifically, 6a ( p ‐OH) displayed the highest antibacterial efficacy against Escherichia coli (MIC = 31.25 µg/mL). Compound 6d ( p ‐Cl) demonstrated the fastest onset of in vivo anti‐inflammatory activity, exceeding diclofenac. Most compounds demonstrated comparable or slightly reduced in vitro anti‐inflammatory activity (81.25%–94.59% hemolysis inhibition). Molecular dynamics simulations confirmed the stability and robust binding interactions at the active sites of COX‐2 and bacterial DNA gyrase B. ADMET predictions indicated favorable bioavailability and drug likeness. This study underscores the potential of the nonacidic quinoline hydrazone scaffold as a versatile platform for the development of multi‐target therapeutics and offers valuable SAR insights to guide the design of safer, more efficacious agents.


  • Eggshell/Kaolin Calcined System: An Efficient, Green, and Recoverable Catalyst for the One-Pot Biginelli Reaction

    by Mourad Bouhedja, Tahir Habila, Ammar Khaled, Mohamed Z. Stiti, Katia M. Saidi, Nafila Bouider, Yazid Meftah, Smail Khelili


  • Synthesis and Exploration of Antibacterial Activity, Molecular Docking, and DFT Studies of Some Benzothiazole–Urea(Thiourea) Hybrid Compounds

    by Nafila Bouider, Kamel Harrouche, Mohamed Zakaria Stiti, Katia Mohand Saidi, Tahir Habila, Smail Khelili

    A series of benzothiazole derivatives ( 3a–o ) were synthesized, structurally characterized by IR, ¹H‐NMR, ¹ 3 C‐NMR, and elemental analysis, and assessed for their in vitro antibacterial efficacy against Staphylococcus aureus , Pseudomonas aeruginosa , Klebsiella pneumoniae , and Escherichia coli . The outcomes revealed differing levels of activity, with compounds 3c , 3j, and 3n identified as the most effective, exhibiting significant inhibition zones and low minimum inhibitory concentrations (MICs) that are comparable to, though typically lower than, those of the reference antibiotic ciprofloxacin. To explore the structure‐activity relationships, density functional theory (DFT) calculations were executed, delivering insights into the electronic characteristics and reactivity of the most active compounds ( 3c , 3n , 3j ). These calculations indicated a link between smaller HOMO–LUMO energy gaps and increased reactivity. Following this, molecular docking studies were performed to investigate the possible action mechanism against S. aureus tyrosyl‐tRNA synthetase (TyrRS), an essential bacterial enzyme. The docking findings displayed favorable binding energies for the active compounds, with 3j (−9.3 Kcal/mol) and 3n (−8.6 Kcal/mol) showing robust interactions, which aligned well with their observed antibacterial effectiveness. An extensive analysis of interaction profiles pinpointed key amino acid residues engaged in binding, suggesting that TyrRS inhibition is a likely mechanism. This study highlights the potential of benzothiazole derivatives, combined with urea and thiourea derivatives, as promising candidates for the development of new antibacterial agents.


  • Graphene Oxide–Graphite Composite Catalysts for Hydrogen Evolution in Sodium Borohydride Methanolysis

    by Bassam A. Najri, Katia Mohand Saidi, Caner Kaya, Derya Yıldız, Arif Kivrak, Hilal Kivrak


  • Efficient and Rapid Solvent‐Free Catalysis of the Biginelli Reaction by Praseodymium (III) Nitrate

    by Mohamed Zakaria Stiti, Tahir Habila, Ammar Khaled, Katia Mohand Saidi, Hanane Mouada, Mourad Bouhedja, Smail Khelili

    The highly effective catalysis of the Biginelli reaction has been demonstrated under solvent‐free conditions, using praseodymium (III) nitrate (Pr(NO 3 ) 3 ·6H 2 O) as a novel catalyst. Notably, this is the first instance of Pr(NO 3 ) 3 ·6H 2 O being used as a catalyst in an organic reaction. This method offers several advantages, including high yields (85%–98%), easy product isolation, shorter reaction time (ranging from 8 to 25 min), and high turnover frequencies (TOFs) of up to 73.5. The solvent‐free nature of the reaction aligns with green chemistry principles by minimizing environmental impact. Additionally, the absence of by‐products ensures a clean and efficient process. Owing to its simplicity and effectiveness, this approach facilitates the synthesis of substituted 3,4‐dihydropyridine‐2 (1 H )‐ones/thiones which have potential applications in the pharmaceutical industry.